Cancer Therapy
Retroperitoneal soft tissue sarcoma treated with postoperative radiotherapy
Published in Cancer Weekly, October 4th, 2005
According to recent research from the United States, "The objective of the current study was to define the optimal treatment for patients 1 with RPS. The authors conducted a review of the pertinent literature and found that the majority of patients had locally advanced RPS at the time of diagnosis."
"Surgery was the mainstay of treatment, and macroscopic total excision was feasible in approximately 50-67% of patients. The 5-year probability of local control was approximately 50%, and the likelihood of developing distant metastasis was approximately 20-30%. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-10-04)
More Articles from Cancer Weekly
- Brain Cancer
TrkA induced apoptosis of neuroblastoma cells via p53-dependent mechanism - Breast Cancer
Catechol-O-methyltransferase polymorphism studied as predictor for breast cancer - Islet Transplantation
Islet hormones and N-nitrosomorpholine have carcinogenic effects - Lymphoma
Ciprofloxacin affected cyclophosphamide pharmacokinetics in NHL patients - Ovarian Cancer
Weekly topotecan administered to heavily pretreated patients - Acute Myeloid Leukemia
PEP005 has potent antileukemic activity mediated via delta isoform of PKC - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
